Akeso Inc
HKEX:9926

Watchlist Manager
Akeso Inc Logo
Akeso Inc
HKEX:9926
Watchlist
Price: 123.9 HKD -0.16% Market Closed
Market Cap: 114.1B HKD

Wall Street
Price Targets

Price Targets Summary
Akeso Inc

Wall Street analysts forecast Akeso Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Akeso Inc is 174.15 HKD with a low forecast of 101 HKD and a high forecast of 237.3 HKD.

Lowest
Price Target
101 HKD
18% Downside
Average
Price Target
174.15 HKD
41% Upside
Highest
Price Target
237.3 HKD
92% Upside
Akeso Inc Competitors:
Price Targets
688177
Bio-Thera Solutions Ltd
55% Upside
4587
PeptiDream Inc
125% Upside
301047
Sino Biological Inc
16% Upside
096530
Seegene Inc
67% Upside
1801
Innovent Biologics Inc
24% Upside
COV
Covalon Technologies Ltd
99% Upside
6160
Beigene Ltd
33% Upside
OPK
OPKO Health Inc
179% Upside

Revenue
Forecast

Revenue Estimate
Akeso Inc

For the last 5 years the compound annual growth rate for Akeso Inc's revenue is 97%. The projected CAGR for the next 3 years is 57%.

97%
Past Growth
57%
Estimated Growth
Estimates Accuracy
-11%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Akeso Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
17%
Average Beat

Net Income
Forecast

Net Income Estimate
Akeso Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
10%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Akeso Inc's stock price target?
Price Target
174.15 HKD

According to Wall Street analysts, the average 1-year price target for Akeso Inc is 174.15 HKD with a low forecast of 101 HKD and a high forecast of 237.3 HKD.

What is Akeso Inc's Revenue forecast?
Projected CAGR
57%

For the last 5 years the compound annual growth rate for Akeso Inc's revenue is 97%. The projected CAGR for the next 3 years is 57%.

Back to Top